237 related articles for article (PubMed ID: 35779777)
1. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
4. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
5. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
Gerdts J; Summers DW; Milbrandt J; DiAntonio A
Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
[TBL] [Abstract][Full Text] [Related]
6. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
[TBL] [Abstract][Full Text] [Related]
7. The chemical biology of NAD
Icso JD; Thompson PR
Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
[TBL] [Abstract][Full Text] [Related]
8. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.
Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L
Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487
[TBL] [Abstract][Full Text] [Related]
9. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
Elife; 2017 Jan; 6():. PubMed ID: 28095293
[TBL] [Abstract][Full Text] [Related]
10. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
11. Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria.
Loreto A; Di Stefano M; Gering M; Conforti L
Cell Rep; 2015 Dec; 13(11):2539-2552. PubMed ID: 26686637
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
[TBL] [Abstract][Full Text] [Related]
13. NAD
Alexandris AS; Koliatsos VE
Antioxid Redox Signal; 2023 Dec; 39(16-18):1167-1184. PubMed ID: 37503611
[No Abstract] [Full Text] [Related]
14. The NAD
Llobet Rosell A; Paglione M; Gilley J; Kocia M; Perillo G; Gasparrini M; Cialabrini L; Raffaelli N; Angeletti C; Orsomando G; Wu PH; Coleman MP; Loreto A; Neukomm LJ
Elife; 2022 Dec; 11():. PubMed ID: 36476387
[TBL] [Abstract][Full Text] [Related]
15. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration.
Di Stefano M; Nascimento-Ferreira I; Orsomando G; Mori V; Gilley J; Brown R; Janeckova L; Vargas ME; Worrell LA; Loreto A; Tickle J; Patrick J; Webster JR; Marangoni M; Carpi FM; Pucciarelli S; Rossi F; Meng W; Sagasti A; Ribchester RR; Magni G; Coleman MP; Conforti L
Cell Death Differ; 2015 May; 22(5):731-42. PubMed ID: 25323584
[TBL] [Abstract][Full Text] [Related]
16. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
[TBL] [Abstract][Full Text] [Related]
17. The SARM1 axon degeneration pathway: control of the NAD
Figley MD; DiAntonio A
Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.
Summers DW; Milbrandt J; DiAntonio A
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8746-E8754. PubMed ID: 30150401
[TBL] [Abstract][Full Text] [Related]
19. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
[TBL] [Abstract][Full Text] [Related]
20. SARM1 can be a potential therapeutic target for spinal cord injury.
Lu Q; Botchway BOA; Zhang Y; Jin T; Liu X
Cell Mol Life Sci; 2022 Feb; 79(3):161. PubMed ID: 35224705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
